Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038 · see citing works

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Slamon, D. J., Godolphin, W. J., Jones, L. A., Holt, J. A., Wong, S., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. A., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,817 · see citing works

Real-time quantification of microRNAs by stem-loop RT-PCR

Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,931 · see citing works

Exploring the metabolic and genetic control of gene expression on a genomic scale.

Derisi, J., Iyer, V., & Brown, P. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,832 · see citing works

miRBase: microRNA sequences, targets and gene nomenclature

Griffiths‐Jones, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 4,713 · see citing works

NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · see citing works

A microRNA polycistron as a potential human oncogene

He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,520 · see citing works

MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer

Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773 · see citing works

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605 · see citing works

MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells

Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557 · see citing works

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882 · see citing works

miR-21-mediated tumor growth

Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600 · see citing works

Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters

Ventura, A., Young, A. G., Winslow, M. M., Lintault, L., Meissner, A., Erkeland, S. J., Newman, J. J., Bronson, R. T., Crowley, D. G., Stone, J. R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.019 · Cited by 1,592 · see citing works

Estrogen-Induced Activation of Erk-1 and Erk-2 Requires the G Protein-Coupled Receptor Homolog, GPR30, and Occurs via Trans-Activation of the Epidermal Growth Factor Receptor through Release of HB-EGF

Filardo, E. J., Quinn, J. A., Bland, K. I., & Frackelton, A. R. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.10.0532 · Cited by 1,387 · see citing works

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C., Zhang, B., Wang, J., Henderson, J., Kutok, J. L., & Rajewsky, K. (2008) · Nature Immunology · doi:10.1038/ni1575 · Cited by 1,225 · see citing works

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Guy, C. T., Webster, M. A., Schaller, M. D., Parsons, T. J., Cardiff, R. D., & Muller, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193 · see citing works

Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells

Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707224200 · Cited by 1,141 · see citing works

MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)

Zhu, S., Si, M.-L., Wu, H., & Mo, Y.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611393200 · Cited by 1,090 · see citing works

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051 · see citing works

Phylogenetic Shadowing and Computational Identification of Human microRNA Genes

Berezikov, E., Guryev, V., van de Belt, J., Wienholds, E., Plasterk, R. H. A., & Cuppen, E. (2005) · Cell · doi:10.1016/j.cell.2004.12.031 · Cited by 1,008 · see citing works

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

Blenkiron, C., Goldstein, L. D., Thorne, N., Spiteri, I., Chin, S., Dunning, M., Barbosa‐Morais, N. L., Teschendorff, A. E., Green, A. R., Ellis, I. O., et al. (2007) · Genome biology · doi:10.1186/gb-2007-8-10-r214 · Cited by 955 · see citing works

A custom microarray platform for analysis of microRNA gene expression

Thomson, J. M., Parker, J. S., Perou, C. M., & Hammond, S. M. (2004) · Nature Methods · doi:10.1038/nmeth704 · Cited by 742 · see citing works

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

Yang, J.-Y., Zong, C. S., Xia, W., Yamaguchi, H., Ding, Q., Xie, X., Lang, J.-Y., Lai, C., Chang, C. J., Huang, W., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1676 · Cited by 698 · see citing works

Interleukin-6–dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer

Löffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A. K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., et al. (2007) · Blood · doi:10.1182/blood-2007-03-081133 · Cited by 637 · see citing works

Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross‐talk with estrogen receptor

Migliaccio, A., Piccolo, D., Castoria, G., Domenico, M. D., Bilancio, A., Lombardi, M., Gong, W., Beato, M., & Auricchio, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2008 · Cited by 627 · see citing works

Cre-lox-regulated conditional RNA interference from transgenes

Ventura, A., Meissner, A., Dillon, C. P., McManus, M. T., Sharp, P. A., Parijs, L. V., Jaenisch, R., & Jacks, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403954101 · Cited by 623 · see citing works

Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer

Sempere, L. F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C. V., Schwartz, G. N., Wells, W. A., Kauppinen, S., & Cole, C. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5019 · Cited by 570 · see citing works

Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis

Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobágyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537 · see citing works

miR-21 Gene Expression Triggered by AP-1 Is Sustained through a Double-Negative Feedback Mechanism

Fujita, S., Ito, T., Mizutani, T., Minoguchi, S., Yamamichi, N., Sakurai, K., & Iba, H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.015 · Cited by 432 · see citing works

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

Yu, D., & Hung, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203972 · Cited by 431 · see citing works

Regulation of Raf-Akt Cross-talk

Moelling, K., Schad, K., Bosse, M., Zimmermann, S., & Schweneker, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111974200 · Cited by 389 · see citing works

Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.

Hellawell, G. O., Turner, G. D. H., Davies, D. R., Poulsom, R., BREWSTER, S. F., & Macaulay, V. M. (2002) · PubMed · Cited by 376 · see citing works

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

Smalley, K. S. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10978 · Cited by 325 · see citing works

Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC

Goga, A., Yang, D., Tward, A. D., Morgan, D. O., & Bishop, J. M. (2007) · Nature Medicine · doi:10.1038/nm1606 · Cited by 324 · see citing works

Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer

Subbaramaiah, K., Norton, L., Gerald, W. L., & Dannenberg, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111415200 · Cited by 315 · see citing works

Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.

Tan, M., Yao, J., & Yu, D. (1997) · PubMed · Cited by 222 · see citing works

Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression

Carvalho, I. P., Milanezi, F., Martins, A. M., Reis, R. M., & Schmitt, F. C. (2005) · Breast Cancer Research · doi:10.1186/bcr1304 · Cited by 207 · see citing works

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis

Fong, S., Itahana, Y., Sumida, T., Singh, J., Coppé, J., Liu, Y., Richards, P. C., Bennington, J. L., Lee, N. M., Debs, R. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2230238100 · Cited by 206 · see citing works

Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway

Paumelle, R., Tulasne, D., Kherrouche, Z., Plaza, S., Leroy, C., Reveneau, S., Vandenbunder, B., & Fafeur, V. (2002) · Oncogene · doi:10.1038/sj.onc.1205297 · Cited by 158 · see citing works

Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression

Higashi, Y., Kanekura, T., & Kanzaki, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000601)86:5 · Cited by 155 · see citing works

A Novel Pathway for Mammary Epithelial Cell Invasion Induced by the Helix-Loop-Helix Protein Id-1

Desprez, P., Lin, C. Q., Thomasset, N., Sympson, C. J., Bissell, M. J., & Campisi, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4577 · Cited by 148 · see citing works

HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1

Bosc, D. G., Goueli, B. S., & Janknecht, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204820 · Cited by 108 · see citing works

The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA

Böhm, M., Sawicka, K., Siebrasse, J. P., Brehmer-Fastnacht, A., Peters, R., & Klempnauer, K.-H. (2003) · Oncogene · doi:10.1038/sj.onc.1206710 · Cited by 101 · see citing works

Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth

Ling, M., Wang, X., Ouyang, X., Lee, T. K., Fan, T., Xu, K., Tsao, S., & Wong, Y. C. (2002) · Oncogene · doi:10.1038/sj.onc.1206007 · Cited by 98 · see citing works

Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression

Nieves-Alicea, R., Colburn, N. H., Simeone, A., & Tari, A. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9993-5 · Cited by 86 · see citing works

HER2 expression in cervical cancer as a potential therapeutic target

Chávez-Blanco, A. D., Pérez-Sánchez, V. M., González‐Fierro, A., Vela-Chávez, T., Candelaria, M., Cetina, L., Vidal, S., & Dueñas‐González, A. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-59 · Cited by 69 · see citing works

A Trimeric Anti-HER2/neu ScFv and Tumor Necrosis Factor-α Fusion Protein Induces HER2/neu Signaling and Facilitates Repair of Injured Epithelia

Huang, T.-H., & Morrison, S. L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095513 · Cited by 29 · see citing works

Gam1-associated alterations of drug responsiveness through activation of apoptosis

Wu, F., Chiocca, S., Beck, W. T., & Mo, Y.-Y. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0771 · Cited by 29 · see citing works

MicroRNAs in Development and Disease

Sayed, D. H., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,074 · see citing works

miRNAs in human cancer

Farazi, T. A., Spitzer, J., Morozov, P. S., & Tuschl, T. (2010) · The Journal of Pathology · doi:10.1002/path.2806 · Cited by 892 · see citing works

MicroRNAs in Human Cancer

Farazi, T. A., Hoell, J. I., Morozov, P. S., & Tuschl, T. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1_1 · Cited by 699 · see citing works

Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21

Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626 · see citing works

Plasma exosome microRNAs are indicative of breast cancer

Hannafon, B. N., Trigoso, Y. D., Calloway, C. L., Zhao, Y. D., Lum, D. H., Welm, A. L., Zhao, Z. J., Blick, K. E., Dooley, W. C., & Ding, W. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0753-x · Cited by 603 · see citing works

The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics

Bautista-Sánchez, D., Arriaga-Canon, C., Pedroza-Torres, A., De La Rosa-Velázquez, I. A., González-Barrios, R., Contreras-Espinosa, L., Montiel-Manríquez, R., Castro-Hernández, C., Fragoso-Ontiveros, V., Álvarez-Gómez, R. M., et al. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.03.003 · Cited by 549 · see citing works

Negative regulation of lncRNA GAS5 by miR-21

Zhang, Z., Zhu, Z., Watabe, K., Zhang, X., Bai, C., Xu, M., Wu, F., & Mo, Y.-Y. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.110 · Cited by 416 · see citing works

Apoptosis and the target genes of microRNA-21

Buscaglia, L. E. B., & Li, Y. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10132 · Cited by 374 · see citing works

MicroRNAs in idiopathic pulmonary fibrosis

Pandit, K. V., Milošević, J., & Kaminski, N. (2011) · Translational research · doi:10.1016/j.trsl.2011.01.012 · Cited by 310 · see citing works

Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer

Gong, C., Yao, Y., Wang, Y., Liu, B., Wu, W. G., Chen, J., Su, F., Yao, H., & Song, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216887 · Cited by 310 · see citing works

The role of microRNAs in endometriosis and associated reproductive conditions

Ohlsson Teague, E. M. C., Print, C. G., & Hull, M. L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp034 · Cited by 309 · see citing works

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management

van Schooneveld, E., Wildiers, H. P. M. W., Vergote, I. B., Vermeulen, P. B., Dirix, L. Y., & Laere, S. V. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0526-y · Cited by 296 · see citing works

Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies

Mittal, S., Kaur, H., Gautam, N., & Mantha, A. K. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.028 · Cited by 295 · see citing works

MicroRNA control of epithelial–mesenchymal transition and metastasis

Zhang, J., & Ma, L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9368-6 · Cited by 273 · see citing works

MicroRNAs in cancer — from research to therapy

Cho, W. C. S. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.11.003 · Cited by 234 · see citing works

Intracellular and Extracellular MicroRNAs in Breast Cancer

Corcoran, C., Friel, A. M., Duffy, M. J., Crown, J. P., & O’Driscoll, L. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.150730 · Cited by 226 · see citing works

MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer

Andorfer, C. A., Necela, B. M., Thompson, E. A., & Perez, E. A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.006 · Cited by 213 · see citing works

Micro RNA s play a central role in molecular dysfunctions linking inflammation with cancer

Tili, E., Michaille, J., & Croce, C. M. (2013) · Immunological Reviews · doi:10.1111/imr.12050 · Cited by 207 · see citing works

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases

Aitken, S. J., Thomas, J. S. J., Langdon, S. P., Harrison, D. J., & Faratian, D. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp427 · Cited by 187 · see citing works

MicroRNAs in regulation of triple-negative breast cancer progression

Piasecka, D., Braun, M., Kordek, R., Sądej, R., & Romańska, H. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2689-2 · Cited by 187 · see citing works

Metastamirs: a stepping stone towards improved cancer management

White, N. M. A., Fatoohi, E., Metias, M., Jung, K., Stephan, C., & Yousef, G. M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.173 · Cited by 185 · see citing works

Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy

Martínez, A. R., de Miguel‐Pérez, D., Ortega, F. G., García-Puche, J. L., Robles‐Fernandez, I., Expósito, J., Martorell‐Marugán, J., Carmona‐Sáez, P., Garrido-Navas, M. C., Rolfo, C. D., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1109-0 · Cited by 180 · see citing works

MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation

Li, Q., Zhang, D., Wang, Y., Sun, P., Hou, X., Larner, J., Xiong, W., & Mi, J. (2013) · Scientific Reports · doi:10.1038/srep02038 · Cited by 176 · see citing works

Regulation of microRNAs in cancer metastasis

Bouyssou, J., Manier, S., Huynh, D., Issa, S., Roccaro, A. M., & Ghobrial, I. M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.02.002 · Cited by 174 · see citing works

Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/ Neu , EGF, and TNF-α in Breast Cancer

Jin, L., Wessely, O., Marcusson, E. G., Ivan, C., Călin, G. A., & Alahari, S. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2162 · Cited by 175 · see citing works

MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs

Aigner, A. M. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0716-0 · Cited by 146 · see citing works

Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease

Wancket, L. M., Frazier, W. J., & Liu, Y. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.11.017 · Cited by 134 · see citing works

MiR‐21 regulates epithelial‐mesenchymal transition phenotype and hypoxia‐inducible factor‐1α expression in third‐sphere forming breast cancer stem cell‐like cells

Han, M., Wang, Y., Liu, M., Bi, X., Bao, J., Zeng, N., Zhu, Z.-K., Mo, Z., Wu, C., & Chen, X. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02281.x · Cited by 129 · see citing works

Heterogeneous Nuclear Ribonucleoprotein C1/C2 Controls the Metastatic Potential of Glioblastoma by Regulating PDCD4

Park, Y. M., Hwang, S. J., Masuda, K., Choi, K.-M., Jeong, M., Nam, D., Gorospe, M., & Kim, H. H. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00443-12 · Cited by 125 · see citing works

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

Aktas, B., Müller, V., Tewes, M., Zeitz, J., Kasimir‐Bauer, S., Loehberg, C. R., Rack, B. K., Schneeweiß, A., & Fehm, T. N. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.04.039 · Cited by 124 · see citing works

Magnetobiosensors Based on Viral Protein p19 for MicroRNA Determination in Cancer Cells and Tissues

Campuzano, S., Torrente-Rodríguez, R. M., López‐Hernández, E., Conzuelo, F., Granados, R., Sánchez-Puelles, J.-M., & Pingarrón, J. M. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403270 · Cited by 119 · see citing works

Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells

Ming-li, H., Liu, M., Wang, Y., Mo, Z., Bi, X., Liu, Z., Fan, Y., Chen, X., & Wu, C. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1195-5 · Cited by 114 · see citing works

The roles of oncogenic miRNAs and their therapeutic importance in breast cancer

O’Bryan, S. M., Dong, S., Mathis, J. M., & Alahari, S. K. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.11.004 · Cited by 112 · see citing works

MicroRNA regulation of innate immune responses in epithelial cells

Zhou, R., O’Hara, S. P., & Chen, X. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.19 · Cited by 111 · see citing works

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features

Lee, H.-J., Park, C. S., Deftereos, G., Morihara, J. K., Stern, J., Hawes, S. E., Swisher, E. M., Kiviat, N. B., & Feng, Q. (2012) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-10-174 · Cited by 109 · see citing works

Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis

Shi, M., Liu, D., Duan, H., Shen, B., & Guo, N. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9265-9 · Cited by 106 · see citing works

MiR-21 Simultaneously Regulates ERK1 Signaling in HSC Activation and Hepatocyte EMT in Hepatic Fibrosis

Zhao, J., Tang, N., Wu, K., Dai, W., Ye, C., Shi, J. G., Zhang, J., Ning, B., Zeng, X. Y., & Lin, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108005 · Cited by 106 · see citing works

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development

Rivas, M. A., Venturutti, L., Huang, Y., Schillaci, R., Huang, T. H. ‐., & Elizalde, P. V. (2012) · Breast Cancer Research · doi:10.1186/bcr3187 · Cited by 105 · see citing works

Exosomes released from neural progenitor cells and induced neural progenitor cells regulate neurogenesis through miR-21a

Ma, Y., Li, C., Huang, Y., Wang, Y., Xia, X., & Zheng, J. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0418-3 · Cited by 105 · see citing works

Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation

Wang, X., Li, C., Ju, S., Wang, Y., Wang, H., & Zhong, R. (2011) · Leukemia & Lymphoma · doi:10.3109/10428194.2011.591004 · Cited by 103 · see citing works

miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2

Zhao, Q., Chen, S., Zhu, Z., Yu, L., Ren, Y., Jiang, M., Weng, J., & Li, B. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1182-9 · Cited by 103 · see citing works

MicroRNA-mediated breast cancer metastasis: from primary site to distant organs

Wang, L., & Wang, J. (2011) · Oncogene · doi:10.1038/onc.2011.444 · Cited by 101 · see citing works

MicroRNA-21 gene and cancer

Huang, Y., Yang, Y. B., Zhang, X. H., Yu, X. L., Wang, Z. B., & Cheng, X. C. (2012) · Medical Oncology · doi:10.1007/s12032-012-0376-8 · Cited by 101 · see citing works

High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation

Dong, G., Liang, X., Wang, D., Gao, H., Wang, L., Wang, L., Liu, J., & Du, Z. (2014) · Medical Oncology · doi:10.1007/s12032-014-0057-x · Cited by 99 · see citing works

Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer

Zhao, Y., Zhao, L., Ischenko, I., Bao, Q., Schwarz, B., Nieß, H., Wang, Y., Renner, A., Mysliwietz, J., Jauch, K., et al. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0360-2 · Cited by 98 · see citing works

Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs

Loayza‐Puch, F., Yoshida, Y., Matsuzaki, T., Takahashi, C., Kitayama, H., & Noda, M. (2010) · Oncogene · doi:10.1038/onc.2010.23 · Cited by 96 · see citing works

Prognostic Significance of Metastasis-Related MicroRNAs in Early Breast Cancer Patients with a Long Follow-up

Markou, A. N., Yousef, G. M., Stathopoulos, E. N., Georgoulias, V., & Lianidou, E. S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.210542 · Cited by 96 · see citing works

β2-AR signaling controls trastuzumab resistance-dependent pathway

Liu, D., Yang, Z., Wang, T., Yang, Z., Chen, H., Hu, Y., Hu, C., Guo, L., Deng, Q., Liu, Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.58 · Cited by 95 · see citing works

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer

Mathe, A., Scott, R. J., & Avery‐Kiejda, K. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226090 · Cited by 95 · see citing works

Curcumin as tyrosine kinase inhibitor in cancer treatment

Golonko, A., Lewandowska, H., Świsłocka, R., Jasińska, U., Priebe, W., & Lewandowski, W. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.015 · Cited by 96 · see citing works

High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer

Anfossi, S., Giordano, A., Gao, H., Cohen, E. N., Tin, S., Wu, Q., Garza, R. J., Debeb, B. G., Álvarez, R. H., Valero, V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083113 · Cited by 91 · see citing works

microRNAs in Cancer Cell Response to Ionizing Radiation

Czochor, J. R., & Glazer, P. M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5718 · Cited by 89 · see citing works

Therapeutic Perspectives of Molecules from Urtica dioica Extracts for Cancer Treatment

Esposito, S., Bianco, A., Russo, R., Maro, A. D., Isernia, C., & Pedone, P. V. (2019) · Molecules · doi:10.3390/molecules24152753 · Cited by 89 · see citing works

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1

Venturutti, L., Russo, R. I. C., Rivas, M. A., Mercogliano, M. F., Izzo, F., Oakley, R. H., Pereyra, M. G., Martino, M. D., Proietti, C. J., Yankilevich, P., et al. (2016) · Oncogene · doi:10.1038/onc.2016.151 · Cited by 86 · see citing works

The role of TGF-β1–miR-21–ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells

Jiang, Y., Chen, X., Tian, W., Yin, X., Wang, J., & Yang, H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.368 · Cited by 85 · see citing works

miRNAs and regulation of cell signaling

Ichimura, A., Ruike, Y., Terasawa, K., & Tsujimoto, G. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08087.x · Cited by 84 · see citing works

The role of oncomirs in the pathogenesis and treatment of breast cancer

Hemmatzadeh, M., Mohammadi, H., Jadidi‐Niaragh, F., Asghari, F., & Yousefi, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.01.026 · Cited by 83 · see citing works

RNA Helicase DDX5 Regulates MicroRNA Expression and Contributes to Cytoskeletal Reorganization in Basal Breast Cancer Cells

Wang, D., Huang, J., & Hu, Z. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.011932 · Cited by 82 · see citing works

Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs

Velagapudi, S. P., Costales, M. G., Vummidi, B. R., Nakai, Y., Angelbello, A. J., Tran, T. A., Haniff, H. S., Matsumoto, Y., Wang, Z. F., Chatterjee, A. K., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.05.015 · Cited by 81 · see citing works

microRNAs in Gliomas: Small Regulators of a Big Problem

Silber, J., James, C. D., & Hodgson, J. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8087-9 · Cited by 80 · see citing works

Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis

Ando, W., Kikuchi, K., Uematsu, T., Yokomori, H., Takaki, T., Sogabe, M., Kohgo, Y., Otori, K., Ishikawa, S., & Okazaki, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-50084-5 · Cited by 80 · see citing works

Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma

Ren, J., Zhu, D., Liu, M., Sun, Y., & Tian, L. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.047 · Cited by 79 · see citing works

MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases

Li, S., Liang, Z., Liu, X., & Zou, F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1052-6 · Cited by 76 · see citing works

MiR-21 Is Required for the Epithelial–Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells

Arısan, E. D., Rencüzoğulları, Ö., Cieza-Borrella, C., Miralles, F., Dwek, M. V., Lange, S., & Onganer, P. U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041557 · Cited by 74 · see citing works

Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma

Sun, S.-S., Zhou, X., Huang, Y.-Y., Kong, L.-P., Mei, M., Guo, W.-Y., Zhao, M.-H., Ren, Y., Shen, Q., & Zhang, L. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0487-x · Cited by 72 · see citing works

Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Sareyeldin, R. M., Gupta, I., Al‐Hashimi, I., Al-Thawadi, H., Farsi, H. F. A., Vranić, S., & Moustafa, A. A. (2019) · Cancers · doi:10.3390/cancers11050646 · Cited by 71 · see citing works

Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients

Toraih, E. A., Mohammed, E. A.-M., Farrag, S. H., Ramsis, N., & Hosny, S. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0143-6 · Cited by 69 · see citing works

Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review

Ismail, A., El‐Mahdy, H. A., Abulsoud, A. I., Sallam, A.-A. M., Eldeib, M. G., Elsakka, E. G. E., Zaki, M. B., & Doghish, A. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.241 · Cited by 67 · see citing works

Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis

Venturutti, L., Romero, L., Urtreger, A., Chervo, M., Russo, R., Mercogliano, M., Inurrigarro, G., Pereyra, M., Proietti, C., Izzo, F., et al. (2016) · Oncogene · doi:10.1038/onc.2015.281 · Cited by 65 · see citing works

miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development

Petrović, N. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0186-3 · Cited by 65 · see citing works

MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival

Mima, K., Nishihara, R., Yang, J., Dou, R., Masugi, Y., Shi, Y. X., da Silva, A., Cao, Y., Song, M., Nowak, J. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2173 · Cited by 65 · see citing works

MicroRNAs: Promising New Antiangiogenic Targets in Cancer

Gallach, S., Fariñas, S. C., Lewintre, E. J., & Camps, C. (2014) · BioMed Research International · doi:10.1155/2014/878450 · Cited by 64 · see citing works

ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy.

Elizalde, P., Russo, R. C., Chervo, M. F., & Schillaci, R. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-16-0360 · Cited by 54 · see citing works

TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cells

Wang, T., Zhang, L., Shi, C., Sun, H., Wang, J., Li, R., Zou, Z., Ran, X., & Su, Y. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.11.012 · Cited by 62 · see citing works

MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype

Santarpia, L., Nicoloso, M. S., & Calin, G. A. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0222 · Cited by 62 · see citing works

The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy

Naeli, P., Yousefi, F., Ghasemi, Y., Savardashtaki, A., & Mirzaei, H. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666191001113511 · Cited by 59 · see citing works

Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer

Chen, Z., Yuan, Y.-C., Wang, Y., Liu, Z., Chan, H. J., & Chen, S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3446-8 · Cited by 59 · see citing works

MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2

Ho, C., Bar, E. E., Giannini, C., Marchionni, L., Karajannis, M. A., Zagzag, D., Gutmann, D. H., Eberhart, C. G., & Rodriguez, F. J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos269 · Cited by 59 · see citing works

The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets

Weidle, U. H., Dickopf, S., Hintermair, C., Kollmorgen, G., Birzele, F., & Brinkmann, U. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20062 · Cited by 56 · see citing works

MicroRNA-21, up-regulated by arsenite, directs the epithelial–mesenchymal transition and enhances the invasive potential of transformed human bronchial epithelial cells by targeting PDCD4

Luo, F., Ji, J., Liu, Y., Xu, Y., Zheng, G., Jing, J., Wang, B., Xu, W., Shi, L., Lü, X., et al. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.11.001 · Cited by 56 · see citing works

MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways

Han, M., Wang, F., Gu, Y., Pei, X., Guo, G., Yu, C., Li, L., Zhu, M., Xiong, Y., & Wang, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4360 · Cited by 54 · see citing works

TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion

Chevalier, C., Collin, G., Descamps, S., Touaitahuata, H., Simon, V., Reymond, N., Fernandez, L., Milhiet, P., Georget, V., Urbach, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10765 · Cited by 53 · see citing works

MicroRNAs and lung cancers: from pathogenesis to clinical implications

Qi, J., & Mu, D. (2012) · Frontiers of Medicine · doi:10.1007/s11684-012-0188-4 · Cited by 52 · see citing works

Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks.

Gomez, G. G., Wykosky, J., Zanca, C., Furnari, F. B., & Cavenee, W. K. (2013) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2013.04.003 · Cited by 52 · see citing works

Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival

Young, J. S., Kawaguchi, T., Yan, L., Qi, Q., Liu, S., & Takabe, K. (2017) · Oncotarget · doi:10.18632/oncotarget.21577 · Cited by 51 · see citing works

A comprehensive review on oncogenic miRNAs in breast cancer

Nurzadeh, M., Naemi, M., & Hasani, S. S. (2021) · Journal of Genetics · doi:10.1007/s12041-021-01265-7 · Cited by 49 · see citing works

MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway

Liu, F., Zheng, S., Liu, T., Liu, Q., Liang, M., Li, X., Sheyhidin, I., Lu, X., & Liu, W. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1693-8 · Cited by 46 · see citing works

Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease

Mehrgou, A., & Akouchekian, M. (2017) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_967_16 · Cited by 46 · see citing works

Deltex-1 Activates Mitotic Signaling and Proliferation and Increases the Clonogenic and Invasive Potential of U373 and LN18 Glioblastoma Cells and Correlates with Patient Survival

Huber, R. M., Rajski, M., Sivasankaran, B., Moncayo, G. E., Hemmings, B. A., & Merlo, A. U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057793 · Cited by 45 · see citing works

MicroRNA Cancer Regulation

Schmitz, U., Wolkenhauer, O., & Vera, J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1 · Cited by 56 · see citing works

MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2

Zhu, D., Gu, L., Li, Z., Jin, W., Lu, Q., & Ren, T. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.01.029 · Cited by 45 · see citing works

MicroRNA-gene signaling pathways in pancreatic cancer

Iliopoulos, D., & Drakaki, A. (2013) · Biomedical Journal · doi:10.4103/2319-4170.119690 · Cited by 44 · see citing works

Engagement of Overexpressed Her2 with GEP100 Induces Autonomous Invasive Activities and Provides a Biomarker for Metastases of Lung Adenocarcinoma

Menju, T., Hashimoto, S., Hashimoto, A., Otsuka, Y., Handa, H., Ogawa, E., Toda, Y., Wada, H., Date, H., & Sabe, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025301 · Cited by 44 · see citing works

Potentially predictive microRNAs of gastric cancer with metastasis to lymph node

Wu, W. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i31.3645 · Cited by 44 · see citing works

Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism

Beltrán‐Anaya, F. O., Cedro‐Tanda, A., Hidalgo‐Miranda, A., & Romero-Cordoba, S. L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00342 · Cited by 44 · see citing works

Urtica dioica extract suppresses miR-21 and metastasis-related genes in breast cancer

Mansoori, B., Mohammadi, A., Hashemzadeh, S., Shirjang, S., Baradaran, A., Asadi, M., Doustvandi, M. A., & Baradaran, B. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.021 · Cited by 43 · see citing works

Small molecule with big role: MicroRNAs in cancer metastatic microenvironments

Su, Y., Li, X., Ji, W., Sun, B., Xu, C., Li, Z., Qian, G., & Su, C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.024 · Cited by 42 · see citing works

Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options

McAnena, P. F., McGuire, A., Ramli, A., Curran, C. E., Malone, C., McLaughlin, R. A., Barry, K., Brown, J. A. L., & Kerin, M. J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4101-7 · Cited by 42 · see citing works

The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers

Wilmott, J. S., Zhang, X. D., Hersey, P., & Scolyer, R. A. (2011) · Pathology · doi:10.1097/pat.0b013e32834a7358 · Cited by 41 · see citing works

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome

Medimegh, I., Omrane, I., Privat, M., Uhrhummer, N., Ayari, H., Belaiba, F., Benayed, F., Benromdhan, K., Mader, S., Bignon, I.-J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111877 · Cited by 41 · see citing works

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051 · see citing works

MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression

Song, B., Wang, C., Liu, J., Wang, X., Lv, L., Wei, L., Xie, L., Zheng, Y., & Song, X. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-29 · Cited by 246 · see citing works

Exploration of the regulatory effect of miR-21 on breast cancer cell line proliferation and invasion as well as the downstream target genes

Kuang, Y., & Nie, Y. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.03.025 · Cited by 18 · see citing works

Expression of miR-145 in breast cancer and its role in invasion and migration of breast cancer cells

Wang, H., Liu, S., Wu, T., Wang, J., Li, X., Chen, W., Lu, H., & Kong, Q. (2015) · Zhonghua jianyan yixue zazhi · doi:10.3760/cma.j.issn.1009-9158.2015.03.011 · Cited by 1 · see citing works

P3-03-04: Targeted Modulation of HER Receptor Signaling in Breast Cancer Using miR-21.

Aubele, M. M., Ludyga, N., Braselmann, H., Atkinson, M., Auer, G., & Anastasov, N. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-p3-03-04